Originator Organization SyntheX, Inc.Startup |
Active Organization- |
Inactive Organization SyntheX, Inc.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | US | SyntheX, Inc.Startup | 12 Oct 2022 |